Soon, get 2nd dose at same spot where you got your first

Gurgaon: Starting Monday, the health department will set up walk-in session sites at the same locations where camps were held between March 4 and April 20 to increase coverage of second-dose recipients.
“Several people due for their second Covishield doses have completed 84 days. We plan to recreate the sites at the same spots exclusively for recipients of second doses to avoid overcrowding,” said Dr Virender Yadav, chief medical officer, Gurgaon.
A total of 17,212 people in the 18-44 age group got inoculated on Friday. In the 45-plus category, 7,744 people took the shots. As many as 116 healthcare staff and 100 frontline workers also received jabs. In all, 25,172 jabs were administered, including 328 at the Huda City Centre metro station and 204 at urban slums. So far, 14,36,819 doses - 11,90,379 first and 2,46,440 second - have been administered in Gurgaon.
The district also received 10,000 doses of Covishield on Friday to add to its existing stock of 12,500 doses at PHCs. It is likely to receive more doses on Monday.
On Saturday, 44 session sites will be set up, including four for Covaxin and 40 for Covishield. Second doses of Covaxin will be administered at the Chauma, Tigra, Manesar and Badshapur PHCs. Two drive-ins will be set up at Start Mall and Space IT Park where both first and second doses of Covishield will be given. Both the sites will have 250 slots for each category. At Huda City Centre metro station, there will be 500 slots each for first and second doses of Covishield.
14 new cases, two more succumb
Meanwhile, the city witnessed 14 fresh cases of Covid-19 on Friday. The caseload now stands at 1,80,699, out of which 110 are active. The positivity rate stands as 0.3%.
On Friday, two deaths were reported, taking the toll to 906. The fatality rate stands at 0.4%. Nine people also recovered, bringing the total number of recoveries to 1,79,683. The recovery rate stands at 99.6%. A total of 94 patients are in home isolation while 16 are in hospitals.